|
1
|
Imagawa A and Tachibana M: Fulminant type
1 diabetes: Recent research progress and future prospects. Diabetol
Int. 11:336–341. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Imagawa A, Hanafusa T, Miyagawa J and
Matsuzawa Y: A novel subtype of type 1 diabetes mellitus
characterized by a rapid onset and an absence of diabetes-related
antibodies. Osaka IDDM study group. N Engl J Med. 342:301–307.
2000.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ikegami H, Imagawa A and Shimada A:
Fulminant type 1 diabetes: Nationwide effort to elucidate genetics,
etiology, and pathogenesis since 2000. Diabetol Int. 11:342–343.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Song SO, Yun JS, Ko SH, Ahn YB, Kim BY,
Kim CH, Jeon JY, Kim DJ, Seo DH, Kim SH, et al: Prevalence and
clinical characteristics of fulminant type 1 diabetes mellitus in
Korean adults: A multi-institutional joint research. J Diabetes
Investig. 13:47–53. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Haneda M, Noda M, Origasa H, Noto H, Yabe
D, Fujita Y, Goto A, Kondo T and Araki E: Japanese clinical
practice guideline for diabetes 2016. Diabetol Int. 9:1–45.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Qiu J, Yin W, Wang R, Luo S and Zhou Z:
Fulminant type 1 diabetes: Focusing on triggering factors. Diabetes
Metab Res Rev. 40(e3731)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Qiu J, Luo S, Yin W, Guo K, Xiang Y, Li X,
Liu Z and Zhou Z: Characterization of immune checkpoint
inhibitor-associated fulminant type 1 diabetes associated with
autoantibody status and ethnic origin. Front Immunol.
13(968798)2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ji Q, Liu H, Wang F, Gao L, Chen K, Quan H
and Lu M: Progression of gestational diabetes mellitus to
pregnancy-associated fulminant type 1 diabetes: A case report. AME
Case Rep. 8(83)2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hanafusa T: Fulminant type 1 diabetes: 20
Years of discovery and development. Diabetol Int. 11:310–314.
2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Imagawa A and Hanafusa T: Fulminant type 1
diabetes-east and west. J Clin Endocrinol Metab. 108:e1473–e1478.
2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kawabata Y and Ikegami H: Genetics of
fulminant type 1 diabetes. Diabetol Int. 11:315–322.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hayakawa T, Nakano Y, Hayakawa K,
Yoshimatu H, Hori Y, Yamanishi K, Yamanishi H, Ota T and Fujimoto
T: Fulminant type 1 diabetes mellitus associated with
Coxsackievirus type B1 infection during pregnancy: A case report. J
Med Case Rep. 13(186)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Oikawa Y and Shimada A: Possible
involvement of autoimmunity in fulminant type 1 diabetes. Diabetol
Int. 11:329–335. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pan Y, Zhong X, Qiu W, Zhao F and Yao J:
New-onset fulminant type 1 diabetes after SARS-CoV-2 infection.
Diabetes Care. 46:e140–e142. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen XY, Wang C, Chen S, Tian M, Wang X
and Zhang L: Fulminant type 1 diabetes mellitus associated with
drug hypersensitivity and Epstein-Barr virus infection: A case
report. Front Pharmacol. 13(884878)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kawasaki E: Anti-islet autoantibodies in
type 1 diabetes. Int J Mol Sci. 24(10012)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yazdanpanah S, Rabiee M, Tahriri M,
Abdolrahim M, Rajab A, Jazayeri HE and Tayebi L: Evaluation of
glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes
and glycemic control: A comprehensive review. Crit Rev Clin Lab
Sci. 54:219–232. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Qiu J, Li X, Chen W, Ma X, Xie Z, Huang G,
Luo S and Zhou Z: The fulminant index: A method of rapidly
differentiating fulminant type 1 diabetes from diabetic
ketoacidosis. Diabetes Metab Res Rev. 38(e3501)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu L, Jia W, Wu Y, Liu R, Zeng C,
Yuanyuan H and Shen J: Plasma glucose to glycated hemoglobin ratio:
Method of differentiating fulminant type 1 diabetes from diabetic
ketoacidosis. Ann Endocrinol (Paris). 80:16–20. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mori JI, Miyakoshi T, Yuzuriha H, Kondo T,
Nishimori E, Naka M, Sato A, Komatsu M, Yamashita K and Aizawa T:
Snap diagnosis of fulminant type 1 diabetes by the normalized
glucose/HbA1c ratio. Endocr J. 71:1093–1096. 2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nebashi H, Matsui H, Tei C, Hasebe M and
Takanashi H: Pregnancy-associated fulminant type 1 diabetes: A case
report and review of the literature. Diabetol Int. 15:589–593.
2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ju IEJ and Nayyar R: Fulminant type 1
diabetes linked with fetal death in utero. BMJ Case Rep.
16(e253585)2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Choy KHA, Wong T, Cao RHM and Flack JR:
Fulminant type 1 diabetes mellitus in a GDM pregnancy: Early
recognition is vital for maternal and fetal outcomes. Endocrinol
Diabetes Metab Case Rep. 2022:22–0262. 2022.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
|
24
|
Calimag APP, Chlebek S, Lerma EV and
Chaiban JT: Diabetic ketoacidosis. Dis Mon.
69(101418)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Spencer NR, Clark SM and Harirah HM:
Management of diabetic ketoacidosis in pregnancy. Clin Obstet
Gynecol. 66:186–195. 2023.PubMed/NCBI View Article : Google Scholar
|
